Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy. [electronic resource]
Producer: 20200903Description: e2121-e2125 p. digitalISSN:- 1526-632X
- Adult
- Analgesics -- therapeutic use
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Humanized -- pharmacology
- Calcitonin Gene-Related Peptide
- Calcitonin Gene-Related Peptide Receptor Antagonists -- pharmacology
- Female
- Humans
- Migraine Disorders -- drug therapy
- Receptors, Calcitonin Gene-Related Peptide -- drug effects
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.